S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13

Avantor Stock Forecast, Price & News

+0.51 (+1.64%)
(As of 07/1/2022 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
4.27 million shs
Average Volume
4.93 million shs
Market Capitalization
$19.29 billion
P/E Ratio
Dividend Yield
Price Target

Avantor Stock Forecast (MarketRank)

Analyst Rating
Moderate Buy
2.94 Rating Score
37.9% Upside
$43.60 Price Target
Short Interest
1.12% of Shares Sold Short
Dividend Strength
Upright™ Environmental Score
News Sentiment
0.54mentions of Avantor in the last 14 days
Based on 7 Articles This Week
Insider Trading
Selling Shares
$1.85 M Sold Last Quarter
Proj. Earnings Growth
From $1.51 to $1.74 Per Share

Overall MarketRank

MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.

3.01 out of 5 stars

Medical Sector

30th out of 1,429 stocks

Analytical Instruments Industry

2nd out of 33 stocks

30 days | 90 days | 365 days | Advanced Chart

Receive AVTR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Avantor and its competitors with MarketBeat's FREE daily newsletter.

Avantor logo

About Avantor (NYSE:AVTR)

Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Avantor, Inc. was founded in 1904 and is headquartered in Radnor, Pennsylvania.

AVTR Stock News Headlines

See More Headlines

Industry, Sector and Symbol

Analytical instruments
Year Founded

Company Calendar

Last Earnings
Next Earnings (Confirmed)
Fiscal Year End

Price Target and Rating

Average Stock Price Forecast
High Stock Price Forecast
Low Stock Price Forecast
Forecasted Upside/Downside
Consensus Rating
Moderate Buy
Rating Score (0-4)
Research Coverage
16 Analysts


Net Income
$572.60 million
Pretax Margin


Sales & Book Value

Annual Sales
$7.39 billion
Cash Flow
$2.10 per share
Book Value
$5.24 per share


Free Float
Market Cap
$19.29 billion
Not Optionable

Avantor Frequently Asked Questions

Should I buy or sell Avantor stock right now?

16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Avantor in the last year. There are currently 1 hold rating and 15 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" Avantor stock.
View analyst ratings for Avantor
or view top-rated stocks.

What is Avantor's stock price forecast for 2022?

16 brokerages have issued 1 year price objectives for Avantor's shares. Their AVTR stock forecasts range from $33.00 to $51.00. On average, they expect Avantor's share price to reach $43.60 in the next twelve months. This suggests a possible upside of 37.9% from the stock's current price.
View analysts' price targets for Avantor
or view top-rated stocks among Wall Street analysts.

How has Avantor's stock performed in 2022?

Avantor's stock was trading at $42.14 at the beginning of 2022. Since then, AVTR shares have decreased by 25.0% and is now trading at $31.61.
View the best growth stocks for 2022 here

Are investors shorting Avantor?

Avantor saw a drop in short interest in the month of May. As of May 31st, there was short interest totaling 6,160,000 shares, a drop of 61.1% from the May 15th total of 15,840,000 shares. Based on an average daily trading volume, of 5,420,000 shares, the days-to-cover ratio is currently 1.1 days. Currently, 1.1% of the shares of the company are sold short.
View Avantor's Short Interest

When is Avantor's next earnings date?

Avantor is scheduled to release its next quarterly earnings announcement on Thursday, July 28th 2022.
View our earnings forecast for Avantor

How can I listen to Avantor's earnings call?

Avantor will be holding an earnings conference call on Friday, July 29th at 8:00 AM Eastern. Interested parties can register for or listen to the call using this link.

How were Avantor's earnings last quarter?

Avantor, Inc. (NYSE:AVTR) announced its quarterly earnings results on Thursday, April, 28th. The company reported $0.38 EPS for the quarter, beating analysts' consensus estimates of $0.35 by $0.03. The business had revenue of $1.95 billion for the quarter, compared to analysts' expectations of $1.93 billion. Avantor had a net margin of 7.72% and a trailing twelve-month return on equity of 32.17%. Avantor's quarterly revenue was up 9.2% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.35 EPS.
View Avantor's earnings history

What guidance has Avantor issued on next quarter's earnings?

Avantor issued an update on its FY 2022 earnings guidance on Monday, May, 9th. The company provided earnings per share guidance of $1.48-$1.54 for the period, compared to the consensus earnings per share estimate of $1.50. The company issued revenue guidance of -.

Who are Avantor's key executives?

Avantor's management team includes the following people:

What other stocks do shareholders of Avantor own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Avantor investors own include (HON), Johnson & Johnson (JNJ), NVIDIA (NVDA), Procter & Gamble (PG), Raytheon Technologies (RTX), Alibaba Group (BABA), CVS Health (CVS), Home Depot (HD), Pfizer (PFE) and QUALCOMM (QCOM).

When did Avantor IPO?

(AVTR) raised $3 billion in an IPO on Friday, May 17th 2019. The company issued 154,000,000 shares at $18.00-$21.00 per share. Goldman Sachs, J.P. Morgan, BofA Merrill Lynch, Barclays and Jefferies acted as the underwriters for the IPO and Credit Suisse, Deutsche Bank Securities, Evercore ISI, Guggenheim Securities, Morgan Stanley, UBS Investment Bank, Citigroup, Cowen, Piper Jaffray, RBC Capital Markets, Baird, William Blair, Janney Montgomery Scott, KeyBanc Capital Markets, PJT Partners, Raymond James, Stephens, Stifel, SunTrust Robinson Humphrey, Wells Fargo Securities and Drexel Hamilton were co-managers.

What is Avantor's stock symbol?

Avantor trades on the New York Stock Exchange (NYSE) under the ticker symbol "AVTR."

How do I buy shares of Avantor?

Shares of AVTR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Avantor's stock price today?

One share of AVTR stock can currently be purchased for approximately $31.61.

How much money does Avantor make?

Avantor (NYSE:AVTR) has a market capitalization of $19.29 billion and generates $7.39 billion in revenue each year. The company earns $572.60 million in net income (profit) each year or $0.889990 on an earnings per share basis.

How many employees does Avantor have?

Avantor employs 13,500 workers across the globe.

How can I contact Avantor?

Avantor's mailing address is BUILDING ONE SUITE 200 100 MATSONFORD ROAD, RADNOR PA, 19087. The official website for Avantor is www.avantorsciences.com. The company can be reached via phone at (610) 386-1700 or via email at [email protected].

This page (NYSE:AVTR) was last updated on 7/2/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.